These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 21352909

  • 1. Folate-decorated maleilated pullulan-doxorubicin conjugate for active tumor-targeted drug delivery.
    Zhang H, Li F, Yi J, Gu C, Fan L, Qiao Y, Tao Y, Cheng C, Wu H.
    Eur J Pharm Sci; 2011 Apr 18; 42(5):517-26. PubMed ID: 21352909
    [Abstract] [Full Text] [Related]

  • 2. Novel folated and non-folated pullulan bioconjugates for anticancer drug delivery.
    Scomparin A, Salmaso S, Bersani S, Satchi-Fainaro R, Caliceti P.
    Eur J Pharm Sci; 2011 Apr 18; 42(5):547-58. PubMed ID: 21371555
    [Abstract] [Full Text] [Related]

  • 3. Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistance.
    Fan L, Li F, Zhang H, Wang Y, Cheng C, Li X, Gu CH, Yang Q, Wu H, Zhang S.
    Biomaterials; 2010 Jul 18; 31(21):5634-42. PubMed ID: 20430433
    [Abstract] [Full Text] [Related]

  • 4. Folate-mediated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting drug delivery.
    Zhang C, Zhao L, Dong Y, Zhang X, Lin J, Chen Z.
    Eur J Pharm Biopharm; 2010 Sep 18; 76(1):10-6. PubMed ID: 20472060
    [Abstract] [Full Text] [Related]

  • 5. Folate-functionalized unimolecular micelles based on a degradable amphiphilic dendrimer-like star polymer for cancer cell-targeted drug delivery.
    Cao W, Zhou J, Mann A, Wang Y, Zhu L.
    Biomacromolecules; 2011 Jul 11; 12(7):2697-707. PubMed ID: 21619062
    [Abstract] [Full Text] [Related]

  • 6. Ligand anchored dendrimers based nanoconstructs for effective targeting to cancer cells.
    Gupta U, Dwivedi SK, Bid HK, Konwar R, Jain NK.
    Int J Pharm; 2010 Jun 30; 393(1-2):185-96. PubMed ID: 20382210
    [Abstract] [Full Text] [Related]

  • 7. Preparation of folate-modified pullulan acetate nanoparticles for tumor-targeted drug delivery.
    Zhang HZ, Li XM, Gao FP, Liu LR, Zhou ZM, Zhang QQ.
    Drug Deliv; 2010 Jan 30; 17(1):48-57. PubMed ID: 22747075
    [Abstract] [Full Text] [Related]

  • 8. Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor.
    Lee ES, Na K, Bae YH.
    J Control Release; 2005 Mar 21; 103(2):405-18. PubMed ID: 15763623
    [Abstract] [Full Text] [Related]

  • 9. Amphiphilic multi-arm-block copolymer conjugated with doxorubicin via pH-sensitive hydrazone bond for tumor-targeted drug delivery.
    Prabaharan M, Grailer JJ, Pilla S, Steeber DA, Gong S.
    Biomaterials; 2009 Oct 21; 30(29):5757-66. PubMed ID: 19643472
    [Abstract] [Full Text] [Related]

  • 10. Polymer conjugates of the highly potent cytostatic drug 2-pyrrolinodoxorubicin.
    Studenovsky M, Ulbrich K, Ibrahimova M, Rihova B.
    Eur J Pharm Sci; 2011 Jan 18; 42(1-2):156-63. PubMed ID: 21075206
    [Abstract] [Full Text] [Related]

  • 11. Folic acid conjugated glycol chitosan micelles for targeted delivery of doxorubicin: preparation and preliminary evaluation in vitro.
    Yu J, Xie X, Wu J, Liu Y, Liu P, Xu X, Yu H, Lu L, Che X.
    J Biomater Sci Polym Ed; 2013 Jan 18; 24(5):606-20. PubMed ID: 23565871
    [Abstract] [Full Text] [Related]

  • 12. Targeted and pH-responsive delivery of doxorubicin to cancer cells using multifunctional dendrimer-modified multi-walled carbon nanotubes.
    Wen S, Liu H, Cai H, Shen M, Shi X.
    Adv Healthc Mater; 2013 Sep 18; 2(9):1267-76. PubMed ID: 23447549
    [Abstract] [Full Text] [Related]

  • 13. Core-crosslinked polymeric micelles with controlled release of covalently entrapped doxorubicin.
    Talelli M, Iman M, Varkouhi AK, Rijcken CJ, Schiffelers RM, Etrych T, Ulbrich K, van Nostrum CF, Lammers T, Storm G, Hennink WE.
    Biomaterials; 2010 Oct 18; 31(30):7797-804. PubMed ID: 20673684
    [Abstract] [Full Text] [Related]

  • 14. Acid-activatable prodrug nanogels for efficient intracellular doxorubicin release.
    Zhan F, Chen W, Wang Z, Lu W, Cheng R, Deng C, Meng F, Liu H, Zhong Z.
    Biomacromolecules; 2011 Oct 10; 12(10):3612-20. PubMed ID: 21905663
    [Abstract] [Full Text] [Related]

  • 15. Folate decorated magnetite nanoparticles: synthesis and targeted therapy against ovarian cancer.
    Fazilati M.
    Cell Biol Int; 2014 Feb 10; 38(2):154-63. PubMed ID: 23956031
    [Abstract] [Full Text] [Related]

  • 16. Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery.
    Prabaharan M, Grailer JJ, Pilla S, Steeber DA, Gong S.
    Biomaterials; 2009 Oct 10; 30(30):6065-75. PubMed ID: 19674777
    [Abstract] [Full Text] [Related]

  • 17. Doxorubicin loaded silica nanorattles actively seek tumors with improved anti-tumor effects.
    Gao F, Li L, Liu T, Hao N, Liu H, Tan L, Li H, Huang X, Peng B, Yan C, Yang L, Wu X, Chen D, Tang F.
    Nanoscale; 2012 Jun 07; 4(11):3365-72. PubMed ID: 22538830
    [Abstract] [Full Text] [Related]

  • 18. Improved drug targeting of cancer cells by utilizing actively targetable folic acid-conjugated albumin nanospheres.
    Shen Z, Li Y, Kohama K, Oneill B, Bi J.
    Pharmacol Res; 2011 Jan 07; 63(1):51-8. PubMed ID: 21035550
    [Abstract] [Full Text] [Related]

  • 19. Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models.
    Gabizon A, Tzemach D, Gorin J, Mak L, Amitay Y, Shmeeda H, Zalipsky S.
    Cancer Chemother Pharmacol; 2010 May 07; 66(1):43-52. PubMed ID: 19779718
    [Abstract] [Full Text] [Related]

  • 20. A comparative study of folate receptor-targeted doxorubicin delivery systems: dosing regimens and therapeutic index.
    Scomparin A, Salmaso S, Eldar-Boock A, Ben-Shushan D, Ferber S, Tiram G, Shmeeda H, Landa-Rouben N, Leor J, Caliceti P, Gabizon A, Satchi-Fainaro R.
    J Control Release; 2015 Jun 28; 208():106-20. PubMed ID: 25869964
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.